Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2011

Feb 10, 2011

29831_dirs_2011-02-09_a28ca9c0-e506-4570-940d-2390177b8b78.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: KING PHARMACEUTICALS INC (KG)
CIK: 0001047699
Period of Report: 2011-01-31

Reporting Person: PFIZER INC (10% Owner)
Reporting Person: Parker Tennessee Corp. (10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, no par value 230719938 Indirect

Footnotes

F1: Reflects shares purchased by Parker Tennessee Corp. ("Purchaser"), a wholly-owned subsidiary of Pfizer Inc. ("Parent"), in a tender offer.

F2: The shares are owned directly by Purchaser. The shares may also be deemed to be indirectly beneficially owned by Parent.